Recent findings from the most important testosterone studies around the world http://www.nebido.com Wed, 19 Jun 2013 01:23:39 +0100 http://www.nebido.com/scripts/pages/en/patients/diagnosis-and-treatment/research-news/metabolic-syndrome-may-influence-the-development-of-prostatic-diseases.php?WT.rss_f=patient&WT.rss_a=Metabolic syndrome may influence the development of prostatic diseases, including benign prostatic hyperplasia and prostate cancer&WT.rss_ev=a Whilst metabolic syndrome is known to be directly associated with a number of cardiovascular diseases and type 2 diabetes there is now growing evidence of its influence on the initiation and clinical progression of prostatic diseases such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa). A recent review of the scientific literature evaluated studies providing evidence of the role of metabolic syndrome in the development and progression of BPH and PCa. In this evaluation the authors considered relevant articles published between 1995 and September 2011 that were identified using one of the main scientific citation databases – PubMed. <br /><br /><a href="http://www.nebido.com/scripts/pages/en/patients/diagnosis-and-treatment/research-news/metabolic-syndrome-may-influence-the-development-of-prostatic-diseases.php?WT.rss_f=patient&WT.rss_a=Metabolic syndrome may influence the development of prostatic diseases, including benign prostatic hyperplasia and prostate cancer&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Mon, 22 Apr 2013 13:00:00 +0100 http://www.nebido.com/scripts/pages/en/patients/diagnosis-and-treatment/research-news/metabolic-syndrome-may-influence-the-development-of-prostatic-diseases.php?WT.rss_f=patient&WT.rss_a=Metabolic syndrome may influence the development of prostatic diseases, including benign prostatic hyperplasia and prostate cancer&WT.rss_ev=a http://www.nebido.com/changes-in-the-worldwide-diagnosis-and-treatment-of-testosterone-deficiency-between-2006-and-2010?WT.rss_f=patient&WT.rss_a=Changes in the worldwide diagnosis and treatment of testosterone deficiency between 2006 and 2010&WT.rss_ev=a This physician-based survey investigated the variations in diagnosing and treating testosterone deficiency (hypogonadism) worldwide in 2010. The study, conducted in Germany, Spain, the United Kingdom, Brazil and Saudi Arabia between April and May 2010, involved 353 physicians who were interviewed to help understand the reasons testosterone therapy was or was not used, physicians’ safety concerns and the actual use of testosterone preparations for treating erectile dysfunction. The results of this survey were compared with a previous survey carried out by the same investigators in 2006 to see what changes in clinical practice have happened over the last 4 years.<br /><br /><a href="http://www.nebido.com/changes-in-the-worldwide-diagnosis-and-treatment-of-testosterone-deficiency-between-2006-and-2010?WT.rss_f=patient&WT.rss_a=Changes in the worldwide diagnosis and treatment of testosterone deficiency between 2006 and 2010&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Mon, 19 Nov 2012 17:00:00 +0100 http://www.nebido.com/changes-in-the-worldwide-diagnosis-and-treatment-of-testosterone-deficiency-between-2006-and-2010?WT.rss_f=patient&WT.rss_a=Changes in the worldwide diagnosis and treatment of testosterone deficiency between 2006 and 2010&WT.rss_ev=a http://www.nebido.com/study-finds-that-low-testosterone-levels-are-common-in-men-with-sexual-problems?WT.rss_f=patient&WT.rss_a=Study finds that low testosterone levels are common in men with sexual problems and may be related to chronic illnesses&WT.rss_ev=a This large retrospective observational study of 990 men with erectile dysfunction (problems achieving or maintaining an erection) looked at the link between low levels of testosterone (also known as hypogonadism) and various chronic illnesses. The average age of men in this study was 57 years and many had chronic conditions such as diabetes mellitus, high blood pressure, work stress and anxiety/depression. Overall, 36% of these men had low testosterone levels.<br /><br /><a href="http://www.nebido.com/study-finds-that-low-testosterone-levels-are-common-in-men-with-sexual-problems?WT.rss_f=patient&WT.rss_a=Study finds that low testosterone levels are common in men with sexual problems and may be related to chronic illnesses&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Tue, 21 Aug 2012 19:00:00 +0100 http://www.nebido.com/study-finds-that-low-testosterone-levels-are-common-in-men-with-sexual-problems?WT.rss_f=patient&WT.rss_a=Study finds that low testosterone levels are common in men with sexual problems and may be related to chronic illnesses&WT.rss_ev=a http://www.nebido.com/observational-cohort-study-examined-the-association-between-testosterone-replacement-therapy?WT.rss_f=patient&WT.rss_a=Observational cohort study examined the association between testosterone replacement therapy and mortality in men with low testosterone levels compared with no testosterone treatment.&WT.rss_ev=a This large retrospective observational cohort study of 1031 men with low testosterone (also known as hypogonadism) from seven Veteran Affairs medical centres in the US was the first to look for a link between testosterone treatment and mortality (death rate) in men with low testosterone. During the three and a half year study, 39% of the men received testosterone replacement therapy (intramuscular injections, testosterone patches or gel), and 61% did not. The mortality of treated men was compared with that of untreated men. The men in the study were aged 40 years or older (average age 62 years), with no history of prostate cancer, but they had a high number of other medical conditions, including diabetes (38%), sexual dysfunction (low libido; 36%) and heart disease (21%).<br /><br /><a href="http://www.nebido.com/observational-cohort-study-examined-the-association-between-testosterone-replacement-therapy?WT.rss_f=patient&WT.rss_a=Observational cohort study examined the association between testosterone replacement therapy and mortality in men with low testosterone levels compared with no testosterone treatment.&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Mon, 06 Aug 2012 16:45:00 +0100 http://www.nebido.com/observational-cohort-study-examined-the-association-between-testosterone-replacement-therapy?WT.rss_f=patient&WT.rss_a=Observational cohort study examined the association between testosterone replacement therapy and mortality in men with low testosterone levels compared with no testosterone treatment.&WT.rss_ev=a http://www.nebido.com/evidence-of-a-key-role-for-testosterone-in-the-cause-and-treatment-of-obesity?WT.rss_f=patient&WT.rss_a=Evidence of a key role for testosterone in the cause and treatment of obesity, the metabolic syndrome and diabetes&WT.rss_ev=a The rapid increase in rates of obesity in both the developed and the developing world has serious consequences. Nearly all obese adults suffer from at least one obesity-related disease, such as type 2 diabetes, high blood pressure, cardiovascular disease, cancer, or joint disorders. A recent comprehensive review has looked beyond the place of testosterone in the male reproductive system and for the treatment of erectile dysfunction (impotence) to examine the key role of testosterone in the development and treatment of obesity and associated diseases. The article reviewed the evidence for the effects on insulin sensitivity, visceral fat and cholesterol levels of returning low testosterone levels to normal, and addressed the safety of testosterone, particularly in elderly men.<br /><br /><a href="http://www.nebido.com/evidence-of-a-key-role-for-testosterone-in-the-cause-and-treatment-of-obesity?WT.rss_f=patient&WT.rss_a=Evidence of a key role for testosterone in the cause and treatment of obesity, the metabolic syndrome and diabetes&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Mon, 21 May 2012 09:00:00 +0100 http://www.nebido.com/evidence-of-a-key-role-for-testosterone-in-the-cause-and-treatment-of-obesity?WT.rss_f=patient&WT.rss_a=Evidence of a key role for testosterone in the cause and treatment of obesity, the metabolic syndrome and diabetes&WT.rss_ev=a http://www.nebido.com/current-state-of-knowledge-on-low-testosterone-in-middle-aged-and-older-men?WT.rss_f=patient&WT.rss_a=Current state of knowledge on low testosterone in middle-aged and older men&WT.rss_ev=a This article reviewed what is known about the consequences of low testosterone (also known as hypogonadism) in middle-aged and older men, with practical information on the benefits and risks of testosterone replacement. The authors examined evidence from a wide range of studies about low testosterone and its treatment to prepare their review.<br /><br /><a href="http://www.nebido.com/current-state-of-knowledge-on-low-testosterone-in-middle-aged-and-older-men?WT.rss_f=patient&WT.rss_a=Current state of knowledge on low testosterone in middle-aged and older men&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Mon, 02 Apr 2012 09:00:00 +0100 http://www.nebido.com/current-state-of-knowledge-on-low-testosterone-in-middle-aged-and-older-men?WT.rss_f=patient&WT.rss_a=Current state of knowledge on low testosterone in middle-aged and older men&WT.rss_ev=a http://www.nebido.com/link-between-low-testosterone-and-frailty-in-elderly-men?WT.rss_f=patient&WT.rss_a=Link between low testosterone and frailty in elderly men&WT.rss_ev=a This review discussed the relationship between low testosterone level and frailty in elderly men and evaluated the evidence which shows that testosterone replacement therapy improves the physical functioning and quality of life of elderly frail men with confirmed low testosterone levels.<br /><br /><a href="http://www.nebido.com/link-between-low-testosterone-and-frailty-in-elderly-men?WT.rss_f=patient&WT.rss_a=Link between low testosterone and frailty in elderly men&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Thu, 08 Mar 2012 09:00:00 +0100 http://www.nebido.com/link-between-low-testosterone-and-frailty-in-elderly-men?WT.rss_f=patient&WT.rss_a=Link between low testosterone and frailty in elderly men&WT.rss_ev=a http://www.nebido.com/evidence-based-criteria-for-diagnosing-low-testosterone-in-aging-men-defined?WT.rss_f=patient&WT.rss_a=Evidence-based criteria for diagnosing low testosterone in aging men defined&WT.rss_ev=a <p>This study, published in the <em>New England Journal of Medicine</em>, identified the most important symptoms linked to late-onset hypogonadism (low testosterone levels in aging men) in a large group of men representative of the general population. When testosterone levels were also taken into consideration, having these three symptoms and low testosterone levels was a specific diagnosis of late-onset hypogonadism.</p><br /><br /><a href="http://www.nebido.com/evidence-based-criteria-for-diagnosing-low-testosterone-in-aging-men-defined?WT.rss_f=patient&WT.rss_a=Evidence-based criteria for diagnosing low testosterone in aging men defined&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Wed, 08 Jun 2011 19:00:00 +0100 http://www.nebido.com/evidence-based-criteria-for-diagnosing-low-testosterone-in-aging-men-defined?WT.rss_f=patient&WT.rss_a=Evidence-based criteria for diagnosing low testosterone in aging men defined&WT.rss_ev=a http://www.nebido.com/increased-risk-of-dying-from-cardiovascular-disease-for-men-with-ed-and-low-testosterone?WT.rss_f=patient&WT.rss_a=Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone&WT.rss_ev=a There is increasing evidence that erectile dysfunction may be a warning sign of a number of disease conditions, such as high blood pressure, metabolic syndrome, diabetes mellitus, depression and coronary heart disease.<br/><br/>Nearly 1700 men attending an andrology clinic for erectile dysfunction were monitored for an average of 4.3 years to find out whether those with low testosterone levels were more likely to suffer a major cardiovascular disease event, such as a heart attack or stroke.<br /><br /><a href="http://www.nebido.com/increased-risk-of-dying-from-cardiovascular-disease-for-men-with-ed-and-low-testosterone?WT.rss_f=patient&WT.rss_a=Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Fri, 01 Apr 2011 17:00:00 +0100 http://www.nebido.com/increased-risk-of-dying-from-cardiovascular-disease-for-men-with-ed-and-low-testosterone?WT.rss_f=patient&WT.rss_a=Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone&WT.rss_ev=a http://www.nebido.com/testosterone-reduces-fat-and-increases-muscle-mass-in-non-obese-men-aged-55-years?WT.rss_f=patient&WT.rss_a=Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years&WT.rss_ev=a Aging is associated with a reduction in testosterone levels in the blood. This reduction causes a number of symptoms, one of which is losing muscle mass.<br /><br />This small, well-designed 12-month study looked at the effect of the testosterone patch on body composition and hormones in 60 men aged ≥55 years who were healthy and not obese, and who had low-to-normal testosterone levels and typical testosterone deficiency symptoms. Blood testosterone levels increased in patients receiving the testosterone patch and decreased in patients receiving placebo. Fat-free mass and skeletal muscle mass increased in the testosterone group but did not change in the placebo group (Figure). Fat mass decreased with testosterone and increased with placebo; these changes were linked to changes in blood testosterone levels.<br /><br />The testosterone patch was shown to be safe but one-third of patients left the study early. The main reason for leaving the study was skin irritation.<br /><br /><a href="http://www.nebido.com/testosterone-reduces-fat-and-increases-muscle-mass-in-non-obese-men-aged-55-years?WT.rss_f=patient&WT.rss_a=Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years&WT.rss_ev=a">Read more</a><br /> menshealthcare@bayerhealthcare.com Tue, 14 Sep 2010 11:00:00 +0100 http://www.nebido.com/testosterone-reduces-fat-and-increases-muscle-mass-in-non-obese-men-aged-55-years?WT.rss_f=patient&WT.rss_a=Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years&WT.rss_ev=a http://www.nebido.com <img src="http://statse.webtrendslive.com/dcs731jyzvz5bdmvsxj67por1_7j4d/dcs.gif?dcsdat=1.37160501921E+12&dcssip=www.nebido.com&dcsuri=%2Fscripts%2Fcomponents%2Fnewslist%2Fen%2Fpatients.php&dcscfg=1&WT.dl=10&WT.rss_f=patient&WT.rss_ev=sv&WT.ti=patient" /> Sat, 01 Jan 2000 13:00:00 +0100